Vhhdoctor.org

INTRACEREBRAL HEMORRHAGE (ICH)
ADMITTING ORDERS
INTRACEREBRAL HEMORRHAGE (ICH) ADMITTING ORDERS
CODE STATUS
DIAGNOSIS
ATTENDING MD: ___________________________
NEUROLOGIST: ___________________________
CARDIOLOGIST: ___________________________

ALLERGIES
WEIGHT ____________ kg
NIHSS Score:_____________________________ Glasgow Coma Scale:________________________________
TREATMENTS
Vital signs & neuro checks every hour  every 2 hours  every 4 hours  Other:_________  Full NIHSS Score on admission, once a shift, prn if change in neuro status  0.9% Normal Saline at ______ ml/hr  Saline Lock  Other:________________________________________________________________________  Bedrest, Head of bed elevated to 30°  Bathroom privileges with assistance only  O2 via nasal cannula to saturation above 96%  Dysphagia screening completed by RN prior to any oral intake or medications given  Strict I&O  NGT tube to intermittent low wall suction if patient shows signs of vomiting
 Seizure precaution
Notify Physician if:
 Neurological change
 Temperature is above 100.4°
 O2 saturation is less than 96%
 Blood sugar is above 150 mg/Hg, if not on sliding scale  Heart rate is above 120, or any other arrhythmia  SBP is above 140 mmHg  SBP is less than 90 mmHg  CPP is less than 70 mmHg (MAP – ICP = CPP)  ICP is greater than _______  NPO, including oral meds until dysphagia screen or speech therapy evaluation completed  NPO except meds, until speech therapy evaluation completed Then Start:
 Regular diet
 Low fat, low cholesterol, 2 gram sodium
INTRACEREBRAL HEMORRHAGE (ICH)
ADMITTING ORDERS
INTRACEREBRAL HEMORRHAGE (ICH) ADMITTING ORDERS
BLOOD PRESSURE
Goal BP __________________________
MANAGEMENT
 Nicardipine (Cardene®) 5 mg/hr (50 ml/hr), increase rate by 2.5 mg/hr every 5 mins (up to 15 mg/hr), once goal Blood Pressure is reached decrease rate to 3 mg/hr  Labetolol (Normodyne®) 10 mg IV bolus x 1. If ineffective, start Labetolol IV at 2 mg/min and titrate to goal Blood Pressure (maximum dose 300 mg or 5 mg/min)  Esmolol (Breviploc®) 500 mcg/kg IV loading dose over one minute then maintenance IV at 50 mcg/kg/min titrate to goal Blood Pressure (maximum dose of 200 mcg/kg/min)  Nitroprusside (Nipride®) 0.25 mcg/kg/min IV maximum dose of 4 mcg/kg/min titrate for  Nitroglycerin 5 mcg/min IV titrate until goal BP is reached (maximum 100 mcg/min)  Other:_______________________________________________________________________ PRNs:
 Hydralazine 5 mg IV every 4 hours prn SBP is above ___________________
 Enalapril 0.625 mg IV every 6 hours prn SBP is above ___________________
 Enalapril 1.25 mg IV every 6 hours prn SBP is above ___________________
 Other:_______________________________________________________________________
All to be done STAT
 Lipid Panel
 Serum osmolality prior to each dose of Mannitol Daily Labs
 CBC
 PT with INR, PTT
 Basic Metabolic Panel
 Serum osmolality
 ABG if intubated
 Daily portable Chest X-ray, if intubated
 Other:________________________________________________________________________
MEDICATIONS
 Mannitol 1 gm/kg IV x 1 dose, then 0.5 gm/kg IV every 6 hours (Hold for osmolality if above  Dulcolax 10 mg PR b.i.d. prn constipation
 Other:_______________________________________________________________________
Pain
 Acetaminophen 650 mg  PO PR every 4 hours prn for mild pain or temp is above 100.5°
 Hydrocodone 5/500 1 tab PO every 4 hours prn for moderate pain
 Hydrocodone 5/500 2 tabs PO every 4 hours prn for severe pain
 Morphine 1 mg IV every 1 hour prn moderate pain
 Morphine 2 mg IV every 1 hour prn severe pain
 Fentanyl 50 mcg IVP every 1 hour prn moderate pain
 Fentanyl 100 mcg IVP every 1 hour prn severe pain
*DO NOT EXCEED 4000 MG ACETAMINOPHEN IN 24 HOURS*
INTRACEREBRAL HEMORRHAGE (ICH)
ADMITTING ORDERS
INTRACEREBRAL HEMORRHAGE (ICH) ADMITTING ORDERS
MEDICATIONS
CONTINUED
 Lorazepam (Ativan®) 2 mg IV every 15 min prn seizures x 2 doses, then call MD  Fosphenytoin (Cerebyx®) loading dose 1 gm IV, then 100 mg IV every 8 hours  Levetiracetam (Keppra®) 500 mg  PO or  IV b.i.d.  Other:_________________________________________________________________
Peptic Ulcer Prophylaxis
 Famotidine (Pepcid®) 20 mg IV every 12 hours
 Famotidine (Pepcid®) 20 mg PO every 12 hours if tolerating PO
 Pantoprazole (Protonix®) 40 mg IV daily
 Pantoprazole (Protonix®) 40 mg PO daily if tolerating PO

Antiemetics
 Ondansetron (Zofran) 4 mg IV every 6 hours prn nausea/vomiting
 Other:__________________________________________________________________
Coagulation Management
 Vitamin K  10 mg in 100 ml NS over 1 hour
 Vitamin K  0.2 mg  0.5 mg  10 mg  SQ  IV  Once daily x 3 days
 Recombinant activated Factor VII  80 mcg/kg x1
160 mcg/kg x1 given within 4 hours of ICH
 For elevated PT/INR of ________:  FFP 2-6 units or  Factor VII 4.8 mg
 For INR above 1.3, 3 units of FFP
 For Fibrinogen less than 200: Cryoprecipitate  10 units  20 units
 For platelets below 100,000: 2 units single donor platelets
 Other:__________________________________________________________________
Electrolyte Replacement
 Potassium 3.8-4, KCl 20 meq IV infusion over 2 hours x 1
 Potassium below 3.8, KCl 40 meq IV infusion over 4 hours x 1
 Magnesium 1-1.5, Magnesium Sulfate 4 gm IVPB to run over 2 hours x 1
 Magnesium 1.6-2, Magnesium Sulfate 2 gm IVPB to run over 2 hours x 1
DIAGNOSTIC
All to be done ASAP
 CT of brain without contrast
 CT Angiogram of the head with contrast
 MRI of brain
 MRA of brain
 Portable CXR
 12 lead EKG
 Carotid Doppler
 2D echocardiogram
 EEG
CONSULTS
 Physical Therapy Evaluation & Treatment  Occupational Therapy Evaluation & Treatment  Speech Therapy for Swallow Evaluation & Treatment  Speech Therapy for Speech & Language Evaluation & Treatment  Dietitian  Case Management for discharge options INTRACEREBRAL HEMORRHAGE (ICH)
ADMITTING ORDERS
INTRACEREBRAL HEMORRHAGE (ICH) ADMITTING ORDERS
 Give patient/family/caregiver Stroke Education Packet on admission EDUCATION
 Provide Smoking Cessation information if a current smoker or has smoked in past 12 months  Diet  Exercise  Weight Management  Medication  Diabetic Teaching (if Diabetic) Approved: ER/JOC _____; Forms 10/13/11; P&T 10/20/11; PIC 10/17/11; MEC 10/19/11; Board 10/25/11 Form # 703.047 Rev 7/12

Source: http://vhhdoctor.org/documents/Stroke/Intracerebral%20Hemorrhage%20Admitting%20Orders%207-2012.pdf

bernhard-hommel.eu

European Journal of Neuroscience, Vol. 21, pp. 591–595, 2005ª Federation of European Neuroscience SocietiesSHORT COMMUNICATIONCaffeine, but not nicotine, enhances visual feature bindingLorenza S. Colzato,1 Sabrina Fagioli,2 Vicki Erasmus1 and Bernhard Hommel11Leiden University, Department of Psychology, Cognitive Psychology Unit, Postbus 9555, 2300 RB Leiden, the Netherlands2University of Ro

astrazeneca-annualreports2010.com

48 GEOGRAPHICAL REVIEW Supplemental new drug applications (sNDAs) were submitted to the FDA for use > espite a continual y chal enging environment, of Seroquel XR in adult patients for major including generic pressure, combined sales of Despite full generic competition to Toprol-XL depressive disorder (MDD) and generalised Arimidex , Crestor , Nexium , Seroquel and Symbicort

Copyright © 2018 Medical Abstracts